TY - JOUR
T1 - ICON 2023
T2 - International Scientific Tendinopathy Symposium Consensus – the core outcome set for Achilles tendinopathy (COS-AT) using a systematic review and a Delphi study of professional participants and patients
AU - de Vos, Robert Jan
AU - Silbernagel, Karin Gravare
AU - Malliaras, Peter
AU - Visser, Tjerk Sleeswijk
AU - Alfredson, Hakan
AU - van den Akker-Scheek, Inge
AU - van Ark, Mathijs
AU - Brorsson, Annelie
AU - Chimenti, Ruth
AU - Docking, Sean
AU - Eliasson, Pernilla
AU - Farnqvist, Kenneth
AU - Haleem, Zubair
AU - Hanlon, Shawn L.
AU - Kaux, Jean Francois
AU - Kearney, Rebecca Samantha
AU - Kirwan, Paul D.
AU - Kulig, Kornelia
AU - Kumar, Bhavesh
AU - Lewis, Trevor
AU - Longo, Umile Giuseppe
AU - Lui, Tun Hing
AU - Maffulli, Nicola
AU - Mallows, Adrian James
AU - Masci, Lorenzo
AU - McGonagle, Dennis
AU - Morrissey, Dylan
AU - Murphy, Myles Calder
AU - Newsham-West, Richard
AU - Nilsson-Helander, Katarina Maria
AU - Norris, Richard
AU - Oliva, Francesco
AU - O’Neill, Seth
AU - Peers, Koen
AU - Rio, Ebonie Kendra
AU - Sancho, Igor
AU - Scott, Alex
AU - Seymore, Kayla D.
AU - Soh, Sze Ee
AU - Vallance, Patrick
AU - Verhaar, Jan A.N.
AU - van der Vlist, Arco C.
AU - Weir, Adam
AU - Zellers, Jennifer Ann
AU - Vicenzino, Bill
N1 - Publisher Copyright:
© Author(s) (or their employer(s)) 2024.
PY - 2024/10/22
Y1 - 2024/10/22
N2 - To develop a core outcome set for Achilles tendinopathy (COS-AT) for use in clinical trials we performed a five-step process including (1) a systematic review of available outcome measurement instruments, (2) an online survey on truth and feasibility of the available measurement instruments, (3) an assessment of the methodological quality of the selected outcome measurement instruments, (4) an online survey on the outcome measurement instruments as COS and (5) a consensus in-person meeting. Both surveys were completed by healthcare professionals and patients. The Outcome Measures in Rheumatology guidelines with a 70% threshold for consensus were followed. We identified 233 different outcome measurement instruments from 307 included studies; 177 were mapped within the International Scientific Tendinopathy Symposium Consensus core domains. 31 participants (12 patients) completed the first online survey (response rate 94%). 22/177 (12%) outcome measurement instruments were deemed truthful and feasible and their measurement properties were evaluated. 29 participants (12 patients) completed the second online survey (response rate 88%) and three outcome measurement instruments were endorsed: the Victorian Institute of Sports Assessment-Achilles questionnaire, the single-leg heel rise test and evaluating pain after activity using a Visual Analogue Scale (VAS, 0–10). 12 participants (1 patient) attended the final consensus meeting, and 1 additional outcome measurement instrument was endorsed: evaluating pain during activity/loading using a VAS (0–10). It is recommended that the identified COS-AT will be used in future clinical trials evaluating the effectiveness of an intervention. This will facilitate comparing outcomes of intervention strategies, data pooling and further progression of knowledge about AT. As COS-AT is implemented, further evidence on measurement properties of included measures and new outcome measurement instruments should lead to its review and refinement.
AB - To develop a core outcome set for Achilles tendinopathy (COS-AT) for use in clinical trials we performed a five-step process including (1) a systematic review of available outcome measurement instruments, (2) an online survey on truth and feasibility of the available measurement instruments, (3) an assessment of the methodological quality of the selected outcome measurement instruments, (4) an online survey on the outcome measurement instruments as COS and (5) a consensus in-person meeting. Both surveys were completed by healthcare professionals and patients. The Outcome Measures in Rheumatology guidelines with a 70% threshold for consensus were followed. We identified 233 different outcome measurement instruments from 307 included studies; 177 were mapped within the International Scientific Tendinopathy Symposium Consensus core domains. 31 participants (12 patients) completed the first online survey (response rate 94%). 22/177 (12%) outcome measurement instruments were deemed truthful and feasible and their measurement properties were evaluated. 29 participants (12 patients) completed the second online survey (response rate 88%) and three outcome measurement instruments were endorsed: the Victorian Institute of Sports Assessment-Achilles questionnaire, the single-leg heel rise test and evaluating pain after activity using a Visual Analogue Scale (VAS, 0–10). 12 participants (1 patient) attended the final consensus meeting, and 1 additional outcome measurement instrument was endorsed: evaluating pain during activity/loading using a VAS (0–10). It is recommended that the identified COS-AT will be used in future clinical trials evaluating the effectiveness of an intervention. This will facilitate comparing outcomes of intervention strategies, data pooling and further progression of knowledge about AT. As COS-AT is implemented, further evidence on measurement properties of included measures and new outcome measurement instruments should lead to its review and refinement.
UR - https://www.scopus.com/pages/publications/85204446524
U2 - 10.1136/bjsports-2024-108263
DO - 10.1136/bjsports-2024-108263
M3 - Article
C2 - 39271248
AN - SCOPUS:85204446524
SN - 0306-3674
VL - 58
SP - 1175
EP - 1186
JO - British Journal of Sports Medicine
JF - British Journal of Sports Medicine
IS - 20
ER -